Proton pump inhibitors: an update of their clinical use and pharmacokinetics Shaojun ShiUlrich Klotz Review Article 05 August 2008 Pages: 935 - 951
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice Laurent Becquemont Review Article 30 August 2008 Pages: 953 - 960
Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects Luis AlmeidaAmílcar FalcãoP. Soares-da-Silva Clinical Trial 06 August 2008 Pages: 961 - 966
Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers P. DoradoI. CavacoA. LLerena Pharmacogenetics 12 June 2008 Pages: 967 - 970
Relationships between specific serum IgE, IgG, IFN-γ level and IFN-γ, IFNR1 polymorphisms in patients with penicillin allergy Na GaoHai-Ling QiaoYue-Wen Zhang Pharmacogenetics 12 June 2008 Pages: 971 - 977
Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics John W. J. HinrichsHarriët M. LooversJan van der Weide Pharmacogenetics 14 June 2008 Pages: 979 - 986
Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria Sue Jean LeeRose McGreadyFrançois Nosten Pharmacokinetics and Disposition Open access 02 July 2008 Pages: 987 - 992
Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration L. T. Diem ThuyL. Ngoc HungK. Na-Bangchang Pharmacokinetics and Disposition 04 July 2008 Pages: 993 - 998
Women encounter ADRs more often than do men Y. ZopfC. RabeH. Dormann Pharmacoepidemiology and Prescription 05 July 2008 Pages: 999 - 1004
Antibiotic prescribing patterns and hospital admissions with respiratory and urinary tract infections Rocío Fernández UrrusunoMiguel Pedregal GonzálezMa. Amparo Torrecilla Rojas Pharmacoepidemiology and Prescription 08 July 2008 Pages: 1005 - 1011
Antiepileptic drug utilization in children from 1997–2005—a study from the Netherlands N. W. van de Vrie-HoekstraT. W. de VriesL. T. W. de Jong-van den Berg Pharmacoepidemiology and Prescription Open access 10 July 2008 Pages: 1013 - 1020
Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials Maurits E. L. ArbouwKris L. L. MovigToine C. G. Egberts Pharmacoepidemiology and Prescription Open access 15 July 2008 Pages: 1021 - 1026
Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate Wonku KangKibum KimYoung-Ran Yoon Short Communication 08 July 2008 Pages: 1027 - 1030
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid R. CordobaE. RamirezF. Hernandez-Navarro Letter to the Editors 27 June 2008 Pages: 1031 - 1032
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam D. Tomalik-ScharteO. DoroshyenkoU. Fuhr Letter to the Editors 28 June 2008 Pages: 1033 - 1035